MALT Lymphoma Prognostic Index (MALT-IPI)
Identifies MALT lymphoma patients at risk of poor outcomes.
Advice
- Patients classified as low or intermediate risk can often be effectively managed with less aggressive treatments.
- High-risk patients may benefit from earlier or more aggressive treatment.
- The MALT-IPI should be utilized as a supplementary tool rather than the sole basis for treatment decisions. It is necessary to integrate the tool's prognostication with comprehensive clinical judgment and to engage in shared decision-making with patients to tailor individual treatment plans.